Sign In

Sabriya Stukes, PhD

Chief Scientific Officer specialized in early stage biotech investments

Sabriya Stukes, PhD, is a Partner at SOSV and serves as the Chief Scientific Officer for IndieBio, a leading seed-stage life science startup development program. Her work primarily focuses on investing in early-stage biotech companies that aim to address critical issues in human and planetary health.12

Professional Background

Before joining SOSV, Stukes was the Operations Director at Stellate Therapeutics, a biotech firm specializing in developing therapeutics for neurological disorders based on gut microbiome metabolites. She also played a significant role in academia as the founding Associate Director of the Master’s in Translational Medicine (MTM) program at The City College of New York, which trains scientists and engineers in medical technology commercialization and healthcare innovation.12

Stukes holds a PhD in Biomedical Sciences from the Albert Einstein College of Medicine. Her expertise spans microbiology, education, and science communication, emphasizing the importance of identifying community needs and designing sustainable healthcare solutions. She has dedicated over a decade to fostering equitable environments in STEM fields.23

Contributions and Philosophy

Stukes is recognized for her commitment to building inclusive and sustainable healthcare solutions that benefit a broad range of communities. She actively engages in initiatives that promote critical thinking and the development of compelling scientific narratives.12

Highlights

Jun 24 · linkedin

What a lovely surprise to find out that The Toronto Star did a great write up of the MaRS Discovery District Health Summit women's health panel I was on along with Jocelyn Wessels, Ph.D. of Afynia Laboratories (IBNY 07), Danielle Brewin Graham and moderated Brittany Barreto, Ph.D. It was a packed audience and really proud to have been able to highlight the work we do in this space.

Also it wouldn't be me if I didn't plug the fact that as always we need to increase funding into scientific research if we ever want to see more meaningful tools and technologies in women's health.

Jun 4 · linkedin

What a great way to start #NYTechWeek - an absolutely packed house for the launch of The Insider Guide to NY for Climate Tech Founders.

In New York City alone over the last four years, $3.5B has been invested in climate tech and nearly 160 climate startups have received venture capital funding!! We recognize that there is so much more work to be done but our hope is that this guidebook is the first step that founders reach for when wanting to know the most critical resources, programs, funds, etc. to help build their #climatetech companies right here in New York.

A massive thanks to Beatriz Franco, Jory Segal, Laura Fox, Daria Siegel, Madeline Behr, Stefan Dienstag for co-creating so much of this and to anyone who helped fill this out, THANK YOU!

As this is an evolving and growing space, and you would like your organization to be on this list, let me know!

Related Questions

What are some of the most promising biotech companies Sabriya Stukes has invested in?
How did Sabriya Stukes transition from academia to venture capital?
What is the Master’s in Translational Medicine (MTM) program at The City College of New York?
How does SOSV support early-stage biotech companies?
What are Sabriya Stukes' key achievements at SOSV?
Sabriya Stukes, PhD
Sabriya Stukes, PhD, photo 1
Sabriya Stukes, PhD, photo 2
Add to my network

Experience

Chief Scientific Officer at IndieBio
Assistant Adjunct Professor at The City College of New York (Jan 2018 - Present); Associate Director, Master's in Translational Medicine at The City College of New York (Dec 2019 - Jan 2021); Operatio at Stellate Therapeutics (Feb 2021 - Mar 2022)

Education

Ph.D. in Microbiology and Immunology from Albert Einstein College of Medicine (2008 - 2014); B.S. in Microbiology and Immunology from Virginia Polytechnic Institute and State University (2001 - 2005)

Location

New York, New York, United States